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Abstract  
Promising polymer membranes of blended biocompatible poly(ε-caprolactone) and 
graphene oxide (PCL/GO) and PCL and partially reduced graphene oxide (PCL/rGO) 
with outstanding water and nutrient transport properties for cell culture bioreactors were 
prepared using phase inversion at mild temperatures. Some of the prepared PCL/GO 
membranes were subjected to a ‘chemical-free’ GO post-reductive process using UV 
(PCL/GO/UV) irradiation. The PCL/rGO membranes exhibited 2.5 times higher flux 
than previously reported biocompatible polymer membranes for cell culture bioreactors, 
which was attributed to the highly interconnected porosity. On the other hand, the 
formation of PCL-graphene oxide composites in the PCL/GO and PCL/GO/UV 
membranes was not conclusive according to spectroscopic analyses, thermal analyses 
and mechanical characterization, probably due to the low graphene oxide loading in the 
membranes (0.1%w/w). The presence of graphene oxide-based nanomaterials in the 
polymer matrix slightly reduced the mechanical properties of the PCL-graphene oxide 
membranes by limiting the polymer chain mobility in comparison to that of the plain 
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PCL membranes. However, their mechanical stability was sufficient for the applications 
pursued. Finally, the biocompatibility assay indicated that the incorporation of GO and 
rGO into the PCL matrix enhanced the uniform distribution and morphology of the 
glioblastoma cells on the surface of the PCL-graphene oxide membranes.  
 
Keywords: Graphene oxide-based nanomaterials; Perfusion bioreactors; Phase 
inversion; Poly(ε-caprolactone) membranes; Tissue engineering 
 
1. INTRODUCTION 
The medical field represents one of the most relevant markets for membranes when 
compared to other industrial applications, aside from the water industry [1]. Different 
relevant applications for membranes in medicine include drug delivery, haemodialysis, 
artificial organs and tissue engineering. Membranes for tissue engineering can be used 
as scaffolds for cells to be implanted in vivo to enhance cell differentiation in tissues 
and in bioreactors for in vitro cell culture proliferation and regeneration of in vitro 3D 
tissues. The 3D tissues regenerated by this technology can be further implanted in vivo 
or used as alternatives to animal models for drug screening or artificial organ supports. 
Particularly, perfusion bioreactors, using membranes as scaffolds, provide a series of 
benefits, such as reducing the internal and external diffusive limitations for nutrient 
transport. Furthermore, perfusion bioreactors enable the application of mechanical 
stimuli on cultured cells, in contrast to other bioreactor designs for tissue engineering 
[1,2]. 
The phase inversion casting technique is a versatile and facile method for producing 
highly porous scaffolds with nanofibrous structures and scalable, 3D, commercial 
membrane products. Phase inversion is the most important method employed for 
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developing nanocomposite polymer membranes for water treatment applications [3]. 
For example, antifouling nanocomposite polyethersulfone (PES) membranes for 
ultrafiltration and nanofiltration have been produced by dispersing carbon nanotubes 
[4], TiO2 particles [4] or graphene oxide (GO) [5] in the polymer solution prior to phase 
inversion. Similarly, to fabricate scaffolds for tissue engineering, the incorporation of 
nanomaterials, such as carbon nanotubes (CNT) [6], graphene [7], hydroxyapatite (HA) 
[8,9], and silver nanoparticles [10,11], in different polymer matrices to achieve 
mechanical reinforcement or to favour chemical or electrical cell stimuli or antibacterial 
properties has been investigated [12]. 
Due to the outstanding structural, optical, mechanical, thermal and electrical properties 
of graphene and its derivatives, these materials have been used in different application 
niches, such as energy, electronics, and biomedicine [13, 14]. Particularly, the 
electroactivity of neural cells has promoted the use of graphene and its derivatives for 
neural tissue regeneration [15]. The biocompatibility and toxicity of graphene and 
graphene derivatives has been the source of controversial discussion among the research 
community. The thorough revision by Volkov et al. [16] showed the potential 
cytotoxicity of graphene and graphene derivatives and the potential risks under different 
types of exposures to these nanomaterials. However, they also found multitude of other 
interesting experimental works, where graphene and graphene derivatives demonstrated 
their improved biocompatibility for different biomedical applications, included 
implantable devices and regenerative medicine. Meanwhile long-term cytotoxic effects 
of graphene and its derivatives are elucidated, the potentiality of these nanomaterials 
should be explored. In our previous work [17], poly(ε-caprolactone) (PCL) membranes 
fabricated using phase inversion exhibited high porosity and a morphology that 
enhanced the adherence and proliferation of the neural type cells. We consider that the 
4 
 
incorporation of small amounts of graphene oxide-based nanomaterials in our former 
PCL membranes may improve the intrinsic properties of the polymer matrix [18], i.e., 
mechanical reinforcement, electrical and/or thermal conductivity, nutrient flux and 
antifouling as well as ameliorating the intrinsic PCL-neural cell biocompatibility. The 
most common fabrication method used to produce PCL/GO composite scaffolds for 
tissue engineering is electrospinning [19-21]. In addition, electrospun composites of 
PCL with commercial graphene [22] and graphene produced using arc discharge 
methods [23] have been prepared. Ramzani and Karimi [24] compared the loading 
effects of graphene nanomaterials on the mechanical properties of electrospun 
composites of PCL with GO and rGO, respectively, and observed a critical graphene 
loading of 0.1wt% in the PCL. While novel needleless electrospinning techniques have 
recently improved the production of electrospun fibers at large scale (up to 1.6 m) [25, 
26], the technique still does not reach the production scale (hundreds of meters) that can 
be achieved by means of phase inversion. Alternative methods to electrospinning for 
producing PCL/GO nanocomposites that have been reported in the literature involve 
solvent casting methods using complex and extreme temperature conditions and 
chemicals [21, 27] or laborious and time consuming in situ polymerization techniques 
[28]. However, to our knowledge, the formation of PCL-graphene oxide composite 
membranes to be used as scaffolds in bioreactors for tissue engineering using the simple 
phase inversion technique under mild conditions has not been reported previously in the 
literature. 
In this work, flat membranes of GO or partially reduced graphene oxide (rGO) with 
PCL were produced using phase inversion under mild temperature conditions and in the 
absence of toxic reductive chemicals. The effects of the oxidation state of the graphene 
oxide nanomaterials on the morphological, chemical and thermal characteristics and 
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mechanical and nutrient transport properties of the PCL-graphene oxide membranes 
were assessed. The possible formation of PCL-graphene oxide nanomaterial composites 
was evaluated. Additionally, glioblastoma cell culture tests were conducted as 
preliminary tests for the biocompatibility of the membranes prepared in this study for 
use in bioreactors for neural tissue engineering.  
 
2. EXPERIMENTAL 
2.1 Materials 
PCL pellets (Mw, 80 kDa), bovine serum albumin (BSA, A9647, Fraction V, p≥ 96%) 
and dibasic sodium phosphate (Na2HPO4) were supplied by Sigma Aldrich, (Spain). 
Graphite powder (99%) and N-methyl pyrrolidone (NMP, 99%, extrapure) were 
purchased from Acros Organics. Sulfuric acid (95-98%) (H2SO4), hydrochloric acid 
(37%) (HCl), potassium permanganate (KMnO4), sodium nitrate (NaNO3), sodium 
chloride (NaCl), potassium chloride (KCl) and potassium dihydrogen phosphate 
(KH2PO4) were provided by Panreac. Hydrogen peroxide (H2O2, 30% v/v) was 
purchased from Scharlab (Spain), and 2-propanol (IPA, 99%) was obtained from Oppac 
(Spain). The aliphatic solvent, Shellshol D70, was supplied by Shell Chemicals (The 
Netherlands). All reagents were used as purchased.  
2.2 Synthesis of the graphene oxide and reduced graphene oxide 
GO was synthesized by chemical oxidation of graphite powder following a modified 
Hummer’s method [29, 30]. Briefly, 3 g of graphite powder and 1.5 g of NaNO3 were 
added to 70 mL of H2SO4, and the mixture was stirred in an ice bath. Next, 9 g of 
KMnO4 was slowly added to the solution at a constant temperature of 35˚C over 20 
minutes. Afterwards, ultrapure water was added, and the temperature was raised to 98˚C 
for 15 minutes. The excess of KMnO4 was removed with H2O2 and washed with 
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ultrapure water to obtain graphite oxide. The graphite oxide was exfoliated using 
ultrasonication (VCX 500, Sonics & Materials, Inc., USA) for 30 minutes and 
centrifuged (Centrifuge 5810, Eppendorf, Spain) for 1 h. The GO powder was dried at 
50˚C for 24 h. 
Reduced graphene oxide (rGO) was synthesized using a hydrothermal method with the 
GO produced previously, according to an adapted method from Ribao et al. [30]. In 
summary, the GO was redispersed in ultrapure water (0.5 mg/mL) by sonication and 
heated at 200˚C during 3 h in a Teflon lined autoclave. The rGO precipitated during this 
process. The rGO was finally dried at 50˚C for 24 h. 
2.3 Preparation of the PCL-graphene oxide flat membranes 
The casting and phase inversion techniques described elsewhere for plain PCL scaffolds 
[17] were adapted here for preparing the PCL-graphene oxide flat membranes. First, a 
dispersion of GO or rGO in NMP was prepared using sonication for 30 minutes. After 
that, PCL was added in the GO/NMP or rGO/NMP dispersion and stirred (Roller 
Shaker 6 Basic, IKA, Spain) for 48 h at 37°C until achieving a uniform PCL solution. 
The weight percentages of PCL and the GO (PCL/GO) or rGO (PCL/rGO) 
nanomaterials in the polymer solution were 15%w/w and 0.1%w/w, respectively. The 
nanomaterial loading was selected based on the critical loading of 0.1wt% that was 
found by Ramzani and Karimi [24] during the preparation of PCL-graphene composites 
using electrospinning techniques. In addition, it was experimentally observed that using 
a 1%w/w graphene loading led to mechanically unstable membranes (see Figure S1 of 
Appendix A. Supplementary material). Lower loading concentrations (0.25 and 
0.5%w/w) were also tested unsuccessfully. The polymer solution was left to degasify 
overnight at room temperature and casted on a glass plate using a doctor blade casting 
knife through a 0.2 mm slit. The casted solution was immediately submerged into a 
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100%v/v IPA coagulation bath until the polymer film was completely precipitated. 
Then, the membrane was placed into a new IPA coagulation bath to complete the 
solvent exchange for 24 h. To completely remove the solvent traces, the PCL/GO and 
PCL/rGO films were subsequently immersed in ultrapure water that was changed 
periodically during 72 h. Furthermore, certain PCL/GO membranes were subjected to a 
UV post-treatment using a UV lamp (365 nm, 6 W, Model EA-160/FE, Spectroline, 
USA) for 48 h, for the purpose of reducing the graphene oxide present in the PCL/GO 
membrane. The membranes obtained from this procedure are referred to as 
PCL/GO/UV. Control membranes containing only PCL (15%w/w PCL in NMP) were 
also prepared for comparison. 
2.3 Physical characterization  
The structure and morphology of the surface and cross section of the PCL-graphene 
oxide membranes were determined using scanning electron microscopy (SEM, EVO 
MA 15, Carl Zeiss, Germany) at a voltage of 20 kV. For the cross-section images, the 
samples were frozen in liquid nitrogen and fractured. All the samples were kept 
overnight at 30˚C under vacuum and were gold sputtered before examination. 
The thickness of the flat scaffolds, δ, was measured using an electronic micrometer 
(Standard, Series 293, Mitutoyo, Spain), and the overall porosity, ε, was quantified 
using a gravimetric method, similar to that of Diban et al. [17]. Samples of the 
membranes were prepared and allowed to dry in a vacuum oven at 30°C for 24 h. The 
samples were then weighed  2W  (AT21 Comparator, Mettler Toledo, Spain) and 
subsequently submerged in Shellshol D70 for 24 h. The excess solvent was wiped with 
a tissue paper, and the samples were weighed again  1W . The value of ε was calculated 
according to the following equation: 
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where Solv  is the density of Shellshol D70 (0.8 g/cm
3
 at 25°C) and PCL  is the density 
of PCL (1.145 g/cm
3
 at 25°C) [31]. The measurements were done in triplicate. 
Additionally, surface porosity of the films, εs, was estimated from the surface SEM 
images using ImageJ software (ImageJ 1.51 d (2016), Wayne Rasband National 
Institutes of Health, USA). 
The quality of the synthesized GO and rGO and the presence of GO or rGO in the PCL-
graphene oxide membranes were characterized using Fourier transform infrared (FTIR) 
spectroscopy (Spectrum 65 spectrometer, Perkin Elmer, Spain) with an ATR sampling 
accessory (GladiATR, PIKE Technologies, USA). 
Thermal gravimetric analyses (TGA) were carried out on a DTG-60H thermobalance 
(Shimadzu, Germany) with a scanning range from room temperature up to 650°C and a 
heating rate of 10˚C min-1 under a nitrogen atmosphere. The mass of the film samples 
ranged from 5 to 10 mg. Differential scanning calorimetry (DSC) with the PCL-
graphene oxide membranes were conducted using DSC-131 instrumentation 
(SETARAM Instrumentation, Germany). The samples (5-10 mg) were heated from 
room temperature to 100˚C at a rate of 10˚C min-1. After a stabilization period of 10 
minutes at 100°C, the sample was cooled down to 0˚C at 10°C min-1, stabilized for 10 
minutes and finally heated again to 100°C at the same rate. The degree of crystallinity, 
C (%), was determined using equation (2) [28]:   
 C 01
m
m




 
         (2) 
where β is the mass fraction of GO or rGO in the PCL film, m  is the sample melting 
enthalpy from the second heating ramp and 0m  is the melting enthalpy for a 100% 
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crystalline PCL (139.5 J g
-1
 [28]). 
Axial tensile tests of the films were conducted using specimens of 406 mm
2
 mounted 
on a servo-hydraulic testing universal machine (SERVOSIS, ME-400, Spain) with a 
load cell capacity of 1.25 kN at a constant speed of 8 mm/s, according to the ISO 
standard for thin plastic films (ASTM D882- 12). The average values of the tensile 
properties were obtained from two replicates. 
2.4 Membrane flux characterization 
The hydraulic and nutrient permeability were determined using a homemade cross-flow 
filtration setup (Figure 1) that consisted of a film holder with a 10 cm
2
 effective 
filtration area, Ae. The polymer membrane divided the holder cell into a feed and 
permeate compartment. The feed was contained in a 2 L feed reservoir with an electrical 
heating coil (Selecta, Spain) to warm the feed solution to a temperature of 37°C. A 
peristaltic pump (model 323E, Watson Marlow, Germany) drove the feed liquid at a 
flow rate of 90 mL min
-1
 through the feed compartment of the membrane test cell, and it 
was recirculated back to the feed reservoir. A valve located at the exit of the cell was 
used to maintain the feed chamber at a pressure slightly above atmospheric pressure. 
The permeate side was opened to the atmosphere. The permeate stream was 
continuously collected, and its weight was automatically recorded in real time. 
The hydraulic permeability of the membranes was determined as follows: the feed 
reservoir was filled with ultrapure water (18.2 MΩ cm, Milli-Q water, Millipore, Spain) 
and heated to 37˚C. Then, the water pressure through the film was maintained at 0.20 
bar for 1 h for film preconditioning and flux stabilization. Afterwards, the flux was 
measured at fixed pressure values during up-down pressure cycles within 0.05 to 0.20 
bars for each membrane specimen. The water flux, wJ (Lm
-2
h
-1
), at each pressure was 
calculated using equation (3), where Ae (m
2
) is the effective membrane surface area and 
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Δt (h) is the time period of permeate collection. The hydraulic permeance, 
wP  (Lm
-2
h
-
1
bar
-1
), was calculated using the slope of the water flux vs. pressure ( P ) plot 
according to equation (4).  
, ,37ºw permeated w C
w
e
W
J
t A


 
        (3) 
w
w
J
P
P


          (4) 
For determining the nutrient permeance, a synthetic solution of the model protein, BSA 
(0.4 g L
-1
), in a phosphate buffer solution (PBS, pH 7.4) was prepared. The films were 
preconditioned in a similar manner as the hydraulic permeance flushing ultrapure water 
at 0.1 bar for 1 h. Then, the BSA solution was circulated at 37 °C through the feed side 
of the membrane test cell at 0.1 bar, and the permeate liquid was collected for 4 h. The 
total BSA solution flux, TJ (L m
-2
h
-1
), and total BSA solution permeance, TP (L m
-2
h
-
1
bar
-1
), were calculated in a similar manner as the water permeation experiments. The 
BSA rejection (RBSA, %) was calculated according to equation (5). The BSA 
concentration in the feed and permeate streams (  1fBSAC mg L  and  1pBSAC mg L , 
respectively) were measured using UV spectrometry (UV-1800 Shimadzu) at a fixed 
wavelength of 280 nm.  
1 100
p
BSA
BSA f
BSA
C
R
C
 
   
 
        (5) 
Both the hydraulic and nutrient permeation tests were conducted in duplicate for each 
membrane. The data are presented as the mean values ± average deviation. 
2.5 Biocompatibility tests and static cell cultures 
The U87 human glioblastoma cell line (ATCC
®
 HTB-14
TM
) was maintained in 
Dulbecco’s-modified Eagle’s medium (DMEM, Gibco Invitrogen, USA) supplemented 
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with 10% calf serum and antibiotic agents (penicillin G (100 U mL
-1
) and streptomycin 
(100 mg mL
-1
)) in a humidified atmosphere of 5% carbon dioxide and 95% air at 37°C.  
The scaffolds were placed on flat-bottom 6-well plates (Corning, Inc., USA) and 
sterilized by immersion in a 70% ethanol solution for 5 minutes.  
The cells were trypsinized from culture flasks, resuspended in culture medium, and 
seeded uniformly onto the membranes at a cell density of 1×10
4
 cells mL
-1
. Plates 
containing the membranes and cells were kept in a humidified atmosphere of 5% carbon 
dioxide and 95% air at 37°C and incubated for different periods of time: 1 day, 6 days 
and 14 days. 
After incubation, the cells were fixed in cold paraformaldehyde (3% in PBS) for 20 
minutes at room temperature, permeabilized with Triton X-100 (0.1% in PBS) for 5 
minutes at room temperature, and washed three times with PBS. Fluorescent-labelled 
phalloidin (Atto-590, Sigma Aldrich, Spain), which interacted with the polymerized f-
actin, was used to identify the actin filaments and fibres. During microscopy 
observation, the membranes were inverted, and a series of optical sections were 
obtained with a Nikon A1R confocal scanning laser microscope (Nikon Corporation, 
Japan) using a Plan Apo VC 20X DIC N2 objective and equipped with a 561 nm laser. 
Reconstructions of the confocal sections were assembled using NIS Elements 3.2 
software.  
 
3. RESULTS AND DISCUSSION 
3.1. Physical characterization 
According to the characterization of TiO2-graphene oxide nanocomposites that were 
prepared previously in our group [30] using similar exfoliation and hydrothermal 
reduction protocols, the GO and rGO prepared herein were expected to form 
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nanoplatelets that were 1-4 graphitic films thick. Micro-photographs of the GO and rGO 
nanomaterials (Figure S2 of Appendix A. Supplementary Material) show evidences of 
delamination into few layers. The surface in rGO nanomaterial seems to be more 
uniform than in GO and therefore in rGO nanomaterials there was a homogeneous 
distribution of the number of layers, while in GO particles different number of layers 
seemed to be overlapped. The dynamic light scattering (DLS) characterization results of 
the particle size distributions of GO and rGO dispersed in NMP are shown in Figure S3 
(Appendix A. Supplementary Material) and indicate that the average particle sizes of 
the dispersed GO and rGO were 295 and 825 nm, respectively. These results might 
indicate the agglomeration of the rGO particles dispersed in NMP. Similar shapes and 
size particle distributions for GO and rGO nanomaterials (823 and 529 nm, 
respectively) measured by DLS were reported by Kumar et al. [7]. However, in that 
study, the chemical reduction of GO led to a reduction in the average particle size. 
Additionally, a small fraction of GO and rGO particles with average sizes of 4801 and 
5560 nm, respectively, was observed. Because the graphene oxide particles were not 
spherical, the particle sizes determined from the spherical approximation model of the 
DLS technique may not have been accurate. Anyways, DLS might preferentially 
measure the length/width of the nanoparticles instead of their thickness. Besides, the 
TEM images of the TiO2-graphene oxide nanomaterial previously described by Ribao et 
al. [30] demonstrated the nanoplatelet shapes of the nanomaterials prepared similarly as 
the GO and rGO reported herein.  
Cross-section and surface SEM images showing the morphology of the membranes are 
shown in Figure 2. The values of the membrane thickness and porosity (bulk and 
surface) are reported in Table 1. The membranes presented porous sponge-like 
structures that are characteristic of phase-separated polymer membranes. The 
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thicknesses of the membranes containing GO and rGO nanoplatelets did not 
significantly change in comparison to the plain PCL membranes. All the PCL-graphene 
oxide membranes presented a highly interconnected porosity throughout their thickness. 
The PCL, PCL/GO and PCL/GO/UV membranes presented a homogeneous porosity 
that was similar to that of previously reported PCL membranes [17, 32]. However, the 
membranes containing graphene oxide-based nanoplatelets had larger pores than the 
pristine PCL membranes (Figure 2). The cross section of the PCL/rGO membranes was 
asymmetric and showed that the pore size progressively increased from the top to the 
bottom of the membrane. Although the PCL/GO and PCL/GO/UV membranes 
presented a slight reduction in the bulk porosity that was statistically significant (in 
contrast to the PCL membranes), this parameter presented values between 75 to 80% for 
all 4 types of membranes (Table 1). Moreover, the pores of the PCL/GO and 
PCL/GO/UV membranes were actually larger than those of the PCL membranes, which 
was qualitatively observed in the cross-section SEM images (Figure 2). However, the 
membrane surface porosity decreased from ~40% to 9% when GO nanoplatelets were 
introduced into the membrane matrix and to 12% when rGO nanoplatelets were 
incorporated. The incorporation of 0.1wt% GO and rGO in the PCL solution reduced 
the viscosity from approximately 4900 cP for the pristine PCL solution to 2900 and 
2800 cP for the PCL/GO and PCL/rGO solutions, respectively. This viscosity reduction 
potentially accelerated the solvent-nonsolvent exchange that occurred during phase 
inversion and led to the formation of larger internal pore sizes and a less porous surface, 
characteristics of a faster demixing process [3, 33]. In summary, the high total porosity 
and qualitative pore sizes of the PCL and PCL-graphene oxide membranes (Figure 2) 
were indicative of microfiltration membranes, ideal for achieving high nutrient transport 
properties and low pore blockage during cell infiltration [34]. 
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The FTIR-ATR spectra of the synthesized GO and rGO nanoplatelets are featured in 
Figure 3(a). The FTIR spectrum of GO showed the representative peaks of the 
nanomaterial, which included the following bands: i) 3551 cm
-1 
corresponding to the 
stretching vibration of the hydroxyl groups (-OH), ii) 1630 cm
-1
 was assigned to the 
skeletal vibrations from unoxidized graphitic domains (C=C), and iii) 1718, 1312, 1152 
and 1026 cm
-1
 were ascribed to the stretching vibrations of oxygen corresponding to 
carboxyl (C=O), carboxyl (C-O), epoxy (C-O) and alkoxy (C-O) groups, respectively 
[35-37]. The characteristic peaks of the oxygenated groups present in the GO clearly 
disappeared for the hydrothermally reduced GO (rGO), demonstrating sufficient 
reduction of the material. Raman spectra of GO and rGO (Figure S4 in the 
supplementary Material) showed the presence of both the G band corresponding to the 
primary in-plane vibration mode of graphene (at 1580-1600 cm
-1
) and the D band 
attributed to the defects of graphene at 3500 cm
-1
 in both nanomaterials. However, the 
absorbance of the rGO was approximately half of that of the GO nanomaterial 
confirming as well the partial reduction of the oxygenated groups observed by FTIR-
ATR. 
Figure 3(b) shows the FTIR-ATR spectra of the PCL and PCL-graphene oxide 
membranes. The characteristic PCL ester bond at 1725 cm
-1
 can be clearly observed in 
all the membranes as well as the characteristic stretching -CH2- vibrational peaks at 
2945 and 2865 cm
-1
. The peak transmittance at 1725 cm
-1
 for PCL was used to 
normalize the signal for the PCL-graphene membranes. The PCL/GO and PCL/GO/UV 
membranes presented the characteristic GO peaks corresponding to the presence of 
unoxidized graphitic domains (C=C) at approximately 1630 cm
-1
. The transmittance 
reduction of the C=C peak intensity and its displacement towards the PCL ester bond 
wavelength (1725 cm
-1
) for the PCL/GO/UV membranes indicated the partial reduction 
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of GO and may indicate possible chemical bonding between the graphene oxide and 
PCL. In the PCL/rGO membranes, the absence of the characteristic rGO transmittance 
peaks was expected due to the absence of the characteristic IR transmittance peaks 
observed for rGO in Figure 3a. 
The thermal properties of the PCL and PCL-graphene oxide membranes are presented in 
Figure 4. In Figure 4(a), the DSC thermograms of the PCL and PCL-graphene oxide 
membranes can be seen. The temperature of crystallization (Tc) was determined from 
the first ramp of cooling, and the melting temperature (Tm) was determined from the 
second heating ramp. The presence of graphene oxide-based nanoplatelets slightly 
increased both the Tc and Tm values compared to those of the plain PCL membranes 
(Table 2). The value of Tc for the PCL membrane increased from 31.75°C to 32.45°C 
for the PCL/rGO membranes and to 33.58°C for the PCL/GO membranes, which 
corresponded to the nucleating effect caused by the presence of graphene oxide-based 
nanoplatelets in the polymer matrix. This result is in agreement with the observed 
increase in the degree of crystallinity, C (%), when graphene oxide-based nanoplatelets 
were incorporated into the matrix of the PCL membranes (Table 2). The slightly higher 
Tc of the PCL/GO membranes could have been caused by van der Waals interactions 
between the PCL and GO [24]. The PCL/GO/UV membranes indicated a reduction in 
crystallinity in comparison to the PCL/GO membranes (Table 2). Although the 
irradiation of UV light through PCL membranes has been reported to cause 
photodegradation of the amorphous phase of the polymer and thus increase the degree 
of crystallinity [38, 39], the UV phototreatment of PCL/starch blend composites with 
5wt% and 20wt% sisal fibres for 6 days reduced the crystallinity between 25% and 60% 
due to the breakdown of the crystalline phase of the PCL chains [38]. 
The TGA curves in Figure 4(b) show the thermal stability of the PCL and PCL-
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graphene oxide membranes. Incorporating graphene oxide-based nanoplatelets at the 
concentration tested in the present study (0.1%w/w) minimally altered the basic thermal 
degradation properties in comparison to the PCL membrane used as a reference. 
However, a slight increase in the initial temperature of degradation was observed when 
rGO nanoplatelets were incorporated (Figure 4(b) and Table 2). The weight loss of the 
PCL/GO membranes observed at approximately 200°C was attributed to traces of NMP 
solvent that remained in the membrane structure. 
Figure 5 and Table 3 show the axial tensile stress-strain curves and characteristic 
mechanical properties, respectively, of the PCL and PCL-graphene oxide membranes. 
At the graphene oxide-based nanoplatelet concentration used in this study (0.1 wt%), 
the elastic modulus and the yield stress of the PCL-graphene oxide membranes did not 
vary significantly in comparison to the pristine PCL membrane properties but slightly 
increased for the PCL/GO and PCL/GO/UV membranes and decreased for the 
PCL/rGO membranes (see Table 3). The presence of graphene oxide-based 
nanoplatelets in the PCL membranes significantly reduced the mechanical properties at 
rupture for the PCL/rGO membranes and slightly decreased them for the PCL/GO and 
PCL/GO/UV membranes in comparison to the plain PCL membranes (Figure 5 and 
Table 3). Similar behaviour was observed by Sayyar et al. [27] and Wang et al. [28] for 
PCL-graphene oxide-based composites prepared by mixing and covalent chemical 
bonding, which was attributed to a restriction of the mobility of the polymer chains due 
to the presence of the graphene oxide-based nanofillers in the polymer matrix. The 
improvement in the ultimate elastic modulus from the PCL/GO to the PCL/GO/UV 
membranes might indicate the presence of certain chemical bonds between PCL and the 
GO nanoplatelets. 
 
17 
 
3.2. Membrane flux 
In Figure 6(a) and (b) the clean water fluxes (L m
-2
 h
-1
) at different transmembrane 
pressures and the hydraulic permeances (L m
-2
 h
-1
 bar
-1
) are presented, respectively. 
Compared with the PCL membrane, the PCL/rGO membranes presented significantly 
higher water fluxes and hydraulic permeances (14437±1860 and 36189±4789 L m
-2
 h
-1
 
bar
-1
 for the PCL and PCL/rGO membranes, respectively). This behaviour could be 
explained by the higher porosity and lower thickness of the limiting layer from the 
water flux observed in the PCL/rGO membrane explained previously. In contrast, the 
PCL/GO (4685±1860 L m
-2
 h
-1
 bar
-1
) and PCL/GO/UV (3507±1067 L m
-2
 h
-1
 bar
-1
) 
membranes suffered a significant decrease in their hydraulic permeance, in contrast to 
the PCL membranes. In this case, the decreased hydraulic permeance was attributed to 
the slight decrease in the porosity from the PCL to the PCL/GO and PCL/GO/UV 
membranes. In comparison to previous works that studied microfiltration polymer 
membranes for tissue engineering bioreactors, the present PCL and PCL-graphene oxide 
membranes exhibited comparable or higher hydraulic permeances (Table 4). For 
instance, Bettahalli et al. [40, 41] reported poly(L-lactic)acid (PLLA) hollow fibre 
membranes with a hydraulic permeance of 2094 L m
-2 
h
-1 
bar
-1
 and commercial 
polyethersulfone (PES) and polysulfone (PS) hollow fibre membranes with a hydraulic 
permeance of 5200 Lm
-2
h
-1
bar
-1
. However, the hydraulic permeance of the commercial 
polypropylene (PP) hollow fibre membrane was 3010 L m
-2 
h
-1 
bar
-1
. Meneghello et al. 
[34] found that blended poly(lactic-co-glycolic acid)/polyvinyl alcohol (PLGA-PVA) 
hollow fibre membranes containing at least 5% PVA had a hydraulic permeance of 
12000 L m
-2 
h
-1 
bar
-1
. In contrast, PLGA-PVA membranes containing lower PVA 
concentrations did not present any water flux. The PCL hollow fibre membranes to be 
used as small blood vessel scaffolds exhibited hydraulic permeances between 200 and 
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800 L m
-2 
h
-1 
bar
-1
 depending on the coagulation bath employed (IPA or water) during 
their fabrication by phase inversion [42]. 
In Figure 6(b), the total permeance of the model BSA solution for the PCL and PCL-
graphene oxide membranes significantly decreased by a factor of 8-17 with respect to 
the hydraulic permeance. However, the PCL/rGO membranes still exhibited a very high 
total BSA solution permeance and low BSA rejection (4140 L m
-2 
h
-1 
bar
-1
 and 1.6%, 
respectively). In contrast to the hydraulic permeance, total cell culture medium-solution 
permeance reductions between 5 and 10 times were also observed in the commercial 
microfiltration PES (from ~5500 to 1040 L m
-2 
h
-1 
bar
-1
), PS (from ~5000 to 660 L m
-2 
h
-1 
bar
-1
) and PP (from ~3000 to 300 L m
-2 
h
-1 
bar
-1
) hollow fibre membranes [41] (Table 
4). This behaviour was attributed to a fouling effect. Among the possible fouling 
mechanisms for microfiltration membranes ((1) internal fouling due to pore narrowing, 
(2) pore blockage due to aggregated proteins and (3) protein deposition on the 
membrane surface [34, 43]), the most likely fouling mechanism in the present 
microfiltration PCL and PCL-graphene oxide membranes was considered to be internal 
fouling due to pore narrowing because of the surface and cross-section morphologies of 
the membranes (the porosity and qualitative pore size SEM images are shown in Figure 
2). Bowen and Gan [44] proposed that this internal fouling phenomena occurred due to 
internal protein adsorption on the microfiltration membranes, which was in agreement 
with the high decrease in the total flux that was observed (approximately 82% for the 
PCL membranes, 95% for the PCL/GO and PCL/GO/UV membranes and 90% for the 
PCL/rGO membranes) during the present filtration experiments and the low BSA 
rejection values (between 2 and 20%), as shown in Figure 6b. According to Haggen-
Poiseulle equation, the flux reduction of the PCL and PCL-graphene oxide membranes 
could be caused by a 3-fold reduction of the effective pore size, that still would remain 
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sufficiently large to allow BSA transport to the permeate side (BSA has approximately a 
hydrodynamic molecular size of 10 nm at the working pH [45]). Despite the total BSA 
solution flux reduction observed in the experiments, a theoretical culture medium 
permeance of 250 L m
-2
h
-1
bar
-1
 was previously found to be sufficient for supplying 
glucose to enable 3-layer cell survival in a bioreactor [41]. Therefore, even the lowest 
permeability membrane, PCL/GO/UV, with a total permeance of 310 L m
-2 
h
-1 
bar
-1
, 
could sustain a multilayered cell culture per unit of the active membrane area.  
3.3. Membrane biocompatibility 
Figure 7 presents confocal microscopy images at different proliferation time points for 
the U87 glioblastoma cells on the PCL and PCL-graphene oxide membranes that were 
used in a preliminary evaluation of their biocompatibility while supporting a culture of 
neural cells for tissue engineering applications. Although the cell adhesion at day 1 in 
the PCL and PCL-graphene oxide membranes was similar, the confocal images show 
that the U87 cells on the PCL membranes formed clusters and were not uniformly 
distributed on the surface. In contrast, the presence of graphene oxide-based 
nanoplatelets in the PCL membranes enhanced the cell distribution during cell 
attachment. Similarly, at days 6 and 14 in the culture, the cells in the PCL membranes 
were scarce and were not uniformly spread throughout the membrane surface. The 
introduction of graphene oxide-based nanoplatelets resulted in a higher cell abundance 
on the membrane surface as well as a sprouted cell morphology in comparison to the 
PCL membranes. Therefore, the presence of graphene oxide-based nanoplatelets on the 
polymer matrix enhanced the PCL membrane biocompatibility towards the neural 
glioblastoma cell line. These results agree with previous works in which scaffolds 
prepared only with graphene [46] or graphene oxide [47] or by incorporating rGO or 
GO nanoplatelets into polymer scaffolds [21, 27] exhibited biocompatibility. Therefore, 
20 
 
these results confirm that the PCL-graphene oxide membranes prepared in the present 
study are potentially useful as scaffolds in bioreactors for neural tissue applications. 
 
4. CONCLUSIONS 
In this study, we developed PCL-graphene oxide membranes that possess outstanding 
transmembrane fluxes for water and BSA protein solutions, which are key features for 
applications in cell culture bioreactors. The PCL-graphene oxide membranes were 
fabricated by using phase inversion techniques, mild temperature conditions and 
nontoxic reductive reagents, in contrast to previously reported methods. The 
spectroscopic and mechanical results indicated that the PCL/GO/UV membranes could 
have formed covalent bonds between PCL and the reduced GO particles; however, the 
thermal DSC observations indicated that van der Waals interactions between PCL and 
the GO nanoplatelets could have occurred. In general, the experimental results did not 
provide solid evidence of the formation of nanocomposites in the PCL-graphene oxide 
membranes, probably due to the low graphene oxide-based nanoplatelets content 
(0.1%w/w) that was successfully loaded into the PCL matrix. Therefore, the PCL-
graphene oxide membranes prepared herein are considered as mixed-matrix membranes. 
The incorporation of graphene oxide-based nanoplatelets into the polymer matrix did 
not reinforce the mechanical properties of the PCL membranes. In contrast, the presence 
of graphene oxide-based nanomaterials might have restricted the polymer chain 
mobility, reducing the elongation and ultimate strain in comparison to the PCL control 
membranes. The PCL-graphene oxide membranes were mechanically stable, and the 
mechanical properties were sufficient to enable their use as scaffolds for cell 
proliferation in perfusion bioreactors. The PCL-graphene oxide membranes exhibited a 
highly interconnected porous structure and, as mentioned previously, had outstanding 
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nutrient transport properties for use in bioreactors in tissue engineering applications. 
Particularly, the PCL/rGO membranes had higher transport properties than the PCL, 
PCL/GO and PCL/GO/UV membranes and other biocompatible polymer membranes 
reported elsewhere. This transport behaviour was attributed to the higher pore size and 
asymmetric pore distribution observed in the PCL/rGO membrane morphology in 
comparison to the PCL, PCL/GO and PCL/GO/UV membranes. The nutrient transport 
properties were characterized by conducting BSA filtration experiments, and the 
PCL/rGO membranes had lower BSA rejection rates and higher permeances than the 
rest of the membranes and could support better multilayered cell cultures in the 
bioreactors.  
Finally, the biocompatibility tests demonstrated that the PCL membranes containing 
graphene oxide-based nanoplatelets presented more uniform glioblastoma cell 
distributions and better cell morphologies in comparison to the plain PCL membranes. 
In conclusion, the PCL-graphene oxide membranes prepared herein by using a facile 
fabrication method and nontoxic reagents presented promising properties and should be 
studied further for dynamic cell culturing and neural stem cell differentiation.  
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APPENDIX A. SUPPLEMENTARY MATERIAL 
The supplementary material of this article includes a comparison of the PCL/GO 
membranes produced using 0.1 %w/w and 1%w/w of GO (Figure S1), micro-
photographs of the surface of the GO and rGO nanomaterials captured by a confocal 
microscope (20X) installed in the Raman spectrometer T64000 (Horiba) (Figure S2), 
the average particle size distributions (Figure S3) of GO and rGO dispersed in NMP 
analysed using DLS (Zetasizer Nano Series, Malvern) with a standard spherical particle 
model and the Raman spectra (Raman spectrometer T64000, Horiba) of the GO and 
rGO nanoplatelets (Figure S4). The excitation wavelength was 514 nm from a Krypton-
Argon laser. The spectrometer is also equipped with a Charge Coupled Device (CCD) 
detector cooled with liquid nitrogen. 
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Figure captions 
Figure 1. Cross-flow filtration setup. 
Figure 2. Cross-section and surface SEM images of the PCL and PCL-graphene 
membranes. The scale bars represent 10 µm. 
Figure 3. FTIR-ATR spectra of the GO and rGO nanomaterials (a) and of the PCL 
and PCL-graphene membranes (b). 
Figure 4. DSC thermograms (a) and TGA profiles (b) of the PCL and PCL-
graphene membranes. The inset in (a) shows a magnification of the melting 
temperature measured during the second heating ramp. 
Figure 5. Tensile stress-strain curves of the PCL and PCL-graphene membranes. 
Figure 6. Clean water flux at different transmembrane pressures (a) and 
comparison of the hydraulic and total model BSA solution permeances and BSA 
rejections (b) of the PCL and PCL-graphene membranes. The statistical 
significance (§) with p<0.05 was calculated using one-way ANOVA considering 
PCL as the reference. 
Figure 7. Confocal microscopy images of the static cell culture of the U87 cells on 
the PCL and PCL-graphene membranes at days 1, 6 and 14, indicating the 
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biocompatibility of the membrane substrates. The red colour highlights the cell 
mitochondria. The scale bar represents 100 µm. 
 
Table 1. Comparison between the morphological parameters of the PCL and PCL-
graphene membranes. The statistical significance (§) with p<0.05 was calculated using 
one-way ANOVA considering PCL as the reference. 
Membrane Thickness, δ (µm) Bulk Porosity, ε (%) Surface Porosity, εs (%) 
PCL 91±5 81±1 40±4 
PCL/GO 85±6 76±1(§) 9±1(§) 
PCL/GO/UV 83±1 77±1(§) 22±2 
PCL/rGO 97±8 80±1 13±2(§) 
 
Table 2. Calorimetric and thermal degradation data derived from the cooling and 
second heating ramp of the DSC and TGA curves of the PCL and PCL-graphene 
membranes.  
Membrane PCL PCL/GO PCL/GO/UV PCL/rGO 
Tc (°C) 31.75 33.58 32.35 32.45 
∆Hc (J/g) -70.72 -62.93 -56.37 -59.89 
Tm (°C) 55.36 55.60 55.59 55.73 
∆Hm (J/g) 48.88 61.21 48.90 57.06 
C (%) 35.04 44.17 35.29 41.18 
Tonset (°C) 272±9 291±11 290±1 319±4 
Tmax (°C) 409±1 411±1 405±5 411±1 
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Table 3. Comparison between the mechanical parameters of the PCL and PCL-
graphene membranes derived from the tensile stress-strain curves. The statistical 
significance (§) with p<0.05 was calculated using one-way ANOVA considering PCL 
as the reference. 
Membrane PCL PCL/GO PCL/GO/UV PCL/rGO 
Young’s modulus (MPa) 23.9±1.9 27.2±2.1 24.0±3.4 16.7±1.5 
Yield point (MPa) 2.9±0.2 2.5±0.5 2.9±0.2 1.8±0.1 
Ultimate tensile strength (MPa) 3.8±0.2 3.7±0.6 4.4±0.2 2.5±0.2(§) 
Ultimate strain (%) 100.5±1.5 69.1±6.5(§) 93.5±18.5 51.1±1.7(§) 
 
Table 4. Comparison of the hydraulic and culture/BSA permeances of the present PCL 
and PCL-graphene oxide membranes with other polymer membranes reported in the 
literature. 
Membrane 
material 
Hydraulic 
permeance  
(L m
-2
 bar
-1
 h
-1
) 
BSA/Culture 
medium permeance 
(L m
-2
 bar
-1
 h
-1
) 
Reference 
PCL 14437±1860 840±450 Present work 
PCL/GO 4685±1860 591±219 Present work 
PCL/GO/UV 3507±1067 310±23 Present work 
PCL/rGO 36189±4789 4140±89 Present work 
PLGA-PVA 12000 - Meneghello et al [34] 
PLLA 2094 - Bettahalli et al [40] 
PES 5200 1040 Bettahalli et al [41] 
PS 5200 660 Bettahalli et al [41] 
PP 3010 300 Bettahalli et al [41] 
PCL 800 - Diban et al [42] 
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Highlights 
 Novel composite membranes for cell culture perfusion bioreactors were prepared 
 Poly(ε-caprolactone) was blended with graphene oxide or reduced graphene 
oxide 
 Phase inversion using non-toxic reductive agents and mild conditions was 
applied   
 The membranes showed exceptionally high water and bovine serum albumin 
fluxes 
 0.1% w/w of graphene in the base membrane improved the neural cell 
biocompatibility 
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Figure 2.  
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Figure 3. 
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Figure 6. 
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Figure 7.  
 
 
